The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening

Overview of attention for article published in Frontiers in oncology, May 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,719 followers.

RRIDs were included in the Frontiers in Oncology paper "The genomic landscape of sensitivity to arsenic tr…" (https://t.co/36o5x6JUhA). Thank you for making your #methodsmatter. #ReproducibleResearch

23 Jun 2023

Reply Repost Favourite

New research: The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening: Introduction Arsenic trioxide (ATO) is a promising anticancer drug for hematological malignancy. Given the dramatic efficacy… #oncology

24 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.